15:26 18/04/2014 Biotech Movers: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals ...
Biotech Movers: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals ...
Gaining Green - 8 hours ago
Biotech Movers: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD). Posted by Stephanie Byars on Apr 18, 2014. On April 17, 2014, Health ...

12:03 18/04/2014 Investor's Watch List -Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Incyte ...
Investor's Watch List -Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Incyte ...
Techsonian (press release) - 12 hours ago
Las Vegas, NV - April 18, 2014 - (TechSonian) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the fourth quarter and fiscal year which ended on December 31, 2013.

16:11 17/04/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
USTrade Voice - Apr 17, 2014
Dallas, Texas 04/17/2014 (ustradevoice) - One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Small Cap Recent Insider Selling: Arena Pharmaceuticals (NASDAQ:ARNA ... - Tech News
Biotech recent insider selling: Arena Pharmaceuticals (NASDAQ:ARNA ... - Gaining Green

14:32 14/04/2014 What Arena's Belviq Television Ad Campaign Means For The Stock
What Arena's Belviq Television Ad Campaign Means For The Stock
Seeking Alpha - Apr 14, 2014
The weight loss drug Belviq from Arena Pharmaceuticals (ARNA) is now being promoted on television with a national advertising campaign.

18:55 11/04/2014 Arena - Belviq Sales Up Modestly Heading Into Television Ads
Arena - Belviq Sales Up Modestly Heading Into Television Ads
Seeking Alpha - Apr 11, 2014
It is certainly an interesting time to be an investor in Arena Pharmaceuticals (ARNA). The company is about 10 months into its launch of the anti-obesity drug Belviq and the equity has taken several lumps along the way.

18:23 08/04/2014 Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
MarketWatch - Apr 8, 2014
Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at: http://www.investor-edge.com/905-register On Monday, shares in Arena Pharmaceuticals Inc. gained 2.57% to close the day at $6.38. The stock recorded a ...

15:48 07/04/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
WallStreetPR - Apr 7, 2014
That being the case, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) seems to have come to the realization that unless it takes proactive steps to expand the market share of its anti-obesity drug Belviq, it might as well miss out on a great opportunity.

20:07 04/04/2014 Arena Script Sales Close Out Quarter On Positive Note
Arena Script Sales Close Out Quarter On Positive Note
Seeking Alpha - Apr 4, 2014
Sales of the Arena Pharmaceuticals (ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter.

13:55 31/03/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expecting Sales to hit $150M this ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expecting Sales to hit $150M this ...
USTrade Voice - Mar 31, 2014
Dallas, Texas 03/31/2014 (ustradevoice) - Biopharmaceutical Company, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), expects majority of its revenue for the year to come from its flagship drug, Belviq.

13:36 24/03/2014 Arena Pharmaceuticals, Inc. (ARNA) news: Direct-To-Consumer Television ...
Arena Pharmaceuticals, Inc. (ARNA) news: Direct-To-Consumer Television ...
Seeking Alpha - Mar 24, 2014
Arena (ARNA) and its marketing partner Eisai (OTCPK:ESALY) recently announced a major new stage in commercialization strategy and promotional mix that I believe could be the tipping point for a significant upward inflection in BELVIQ sales.